| Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course C Parra-Herran, CM Quick, BE Howitt, P Dal Cin, BJ Quade, MR Nucci The American Journal of Surgical Pathology 39 (2), 157-168, 2015 | 107 | 2015 |
| Myxoid leiomyosarcoma of the uterus: a clinicopathologic analysis of 30 cases and review of the literature with reappraisal of its distinction from other uterine myxoid … C Parra-Herran, JK Schoolmeester, L Yuan, P Dal Cin, CDM Fletcher, ... The American Journal of Surgical Pathology 40 (3), 285-301, 2016 | 95 | 2016 |
| Synthesis of diagnostic quality cancer pathology images by generative adversarial networks AB Levine, J Peng, D Farnell, M Nursey, Y Wang, JR Naso, H Ren, ... The Journal of pathology 252 (2), 178-188, 2020 | 81 | 2020 |
| Cervical squamocolumnar junction–specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions M Herfs, C Parra-Herran, BE Howitt, AR Laury, MR Nucci, S Feldman, ... The American journal of surgical pathology 37 (9), 1311-1318, 2013 | 81 | 2013 |
| Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups C Parra-Herran, J Lerner-Ellis, B Xu, S Khalouei, D Bassiouny, M Cesari, ... Modern Pathology 30 (12), 1748-1759, 2017 | 80 | 2017 |
| International endocervical adenocarcinoma criteria and classification: validation and interobserver reproducibility A Hodgson, KJ Park, B Djordjevic, BE Howitt, MR Nucci, E Oliva, ... The American journal of surgical pathology 43 (1), 75-83, 2019 | 76 | 2019 |
| Molecular changes in endometriosis-associated ovarian clear cell carcinoma MJ Worley Jr, S Liu, Y Hua, JSL Kwok, A Samuel, L Hou, M Shoni, S Lu, ... European Journal of Cancer 51 (13), 1831-1842, 2015 | 72 | 2015 |
| Cystic lesions of the pancreas: clinical and pathologic review of cases in a five year period CE Parra-Herran, MT Garcia, L Herrera, PA Bejarano JOP. Journal of the Pancreas 11 (4), 358-364, 2010 | 72 | 2010 |
| Histopathology of placenta creta: chorionic villi intrusion into myometrial vascular spaces and extravillous trophoblast proliferation are frequent and specific findings with … C Parra-Herran, B Djordjevic International Journal of Gynecological Pathology 35 (6), 497-508, 2016 | 71 | 2016 |
| International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome A Hodgson, E Olkhov-Mitsel, BE Howitt, MR Nucci, C Parra-Herran Journal of clinical pathology 72 (5), 347-353, 2019 | 68 | 2019 |
| Immunohistochemistry in the diagnosis of mucinous neoplasms involving the ovary: the added value of SATB2 and biomarker discovery through protein expression database mining S Strickland, JK Wasserman, A Giassi, B Djordjevic, C Parra-Herran International Journal of Gynecological Pathology 35 (3), 191-208, 2016 | 61 | 2016 |
| High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent: TP53: Pathway Alterations and Aggressive Behavior A Hodgson, Y Amemiya, A Seth, B Djordjevic, C Parra-Herran The American journal of surgical pathology 41 (11), 1513-1522, 2017 | 60 | 2017 |
| Uterine mesenchymal tumors: update on classification, staging, and molecular features C Parra-Herran, BE Howitt Surgical pathology clinics 12 (2), 363-396, 2019 | 55 | 2019 |
| Pattern-based classification of invasive endocervical adenocarcinoma, depth of invasion measurement and distinction from adenocarcinoma in situ: interobserver variation among … C Parra-Herran, M Taljaard, B Djordjevic, MC Reyes, L Schwartz, ... Modern Pathology 29 (8), 879-892, 2016 | 49 | 2016 |
| p53, mismatch repair protein, and POLE abnormalities in ovarian clear cell carcinoma: an outcome-based clinicopathologic analysis C Parra-Herran, D Bassiouny, J Lerner-Ellis, E Olkhov-Mitsel, N Ismiil, ... The American journal of surgical pathology 43 (12), 1591-1599, 2019 | 43 | 2019 |
| Genomic abnormalities in invasive endocervical adenocarcinoma correlate with pattern of invasion: biologic and clinical implications A Hodgson, Y Amemiya, A Seth, M Cesari, B Djordjevic, C Parra-Herran Modern Pathology 30 (11), 1633-1641, 2017 | 42 | 2017 |
| Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT‐rich sequence‐binding protein 2 in their distinction from primary ovarian … S Strickland, C Parra‐Herran Histopathology 68 (7), 977-987, 2016 | 42* | 2016 |
| CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma MR Ortega, N Usmani, C Parra-Herran, DJ Adams, B Steingo, ... Neurology 79 (7), 715-716, 2012 | 42 | 2012 |
| Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour IM Schaefer, JL Hornick, LM Sholl, BJ Quade, MR Nucci, C Parra‐Herran Histopathology 70 (7), 1138-1146, 2017 | 41 | 2017 |
| Ductal carcinoma in situ of the breast: an update for the pathologist in the era of individualized risk assessment and tailored therapies WM Hanna, C Parra-Herran, FI Lu, E Slodkowska, E Rakovitch, ... Modern Pathology 32 (7), 896-915, 2019 | 39 | 2019 |
Anjelica HodgsonUniversity Health Network - Toronto General Hospital在 uhn.ca 的電子郵件地址已通過驗證
